Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma

Q: Why is Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma ordered?

Providers order this test when results can help evaluate symptoms, monitor conditions, or guide treatment.

Q: How do I prepare for Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma?

Preparation depends on the specific test and your provider’s instructions.

LOINC: 77619-5Type: OtherCPT: N/A

Medical Disclaimer: This information is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

Frequently Asked Questions

A diagnostic test used to support clinical decision-making.

Sources

[1]LOINC — Logical Observation Identifiers Names and Codes. Regenstrief Institute

Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma

Frequently Asked Questions

What is Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma?

Why is Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma ordered?

How do I prepare for Fetal chromosome 13+18+21+Y aneuploidy [Presence] based on dosage of chromosome-specific cell-free DNA from Maternal plasma?